Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption
- PMID: 1449141
Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption
Abstract
AIDS-associated gastric secretory failure has been characterized by decreased secretion of acid, pepsin, and gastric juice volume. To determine whether decreased intrinsic factor secretion and vitamin B12 malabsorption occur in this entity, we performed prospective measurements of maximal acid output, intrinsic factor output, vitamin B12 absorption, serum vitamin B12, and holotranscobalamin II in 10 consecutive AIDS patients. Four of 10 patients had low maximal acid output, i.e., < or = 1.5 mEq/h (control = 12.8 +/- 9.0, range 2.5-25 mEq/h). Four patients had low intrinsic factor output, i.e., < or = 1.1 microgram/h (control = 8.2 +/- 6.9, range 3.1-19.4 micrograms/h). One patient with low intrinsic factor output had low serum vitamin B12 and a Schilling test consistent with pernicious anemia. A second patient with very low intrinsic factor output (0.16 micrograms/h) had low parts I and II Schilling tests; malabsorption most likely resulted from both low intrinsic factor secretion and ileal disease. One of three vitamin B12 malabsorbing patients, with normal serum vitamin B12, had low holotranscobalamin II, 25 pg/ml (control holotranscobalamin II = 76 +/- 44, range 44-152 pg/ml). Maximal acid output and intrinsic factor output did not correlate in AIDS (r = 0.36, p = 0.30) in contrast to the expected correlation in controls (r = 0.91, p = 0.03). We conclude that low intrinsic factor secretion is common in AIDS and contributes to vitamin B12 malabsorption. Decreased parietal cell secretion of intrinsic factor and acid may occur independently in human immunodeficiency virus-associated gastric secretory failure. Low holotranscobalamin II, an early manifestation of vitamin B12 malabsorption, results in decreased delivery to vitamin B12-dependent tissues prior to depletion of serum vitamin B12. Regular supplementation with vitamin B12 may therefore be warranted in patients with advanced HIV infection.
Similar articles
-
Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome.Arch Intern Med. 1989 Sep;149(9):2039-41. Arch Intern Med. 1989. PMID: 2774781
-
[Transient malabsorption of Vitamin B12 bound to intrinsic factor in pernicious anemia (author's transl)].Nouv Rev Fr Hematol. 1975 Jan-Feb;15(1):107-18. Nouv Rev Fr Hematol. 1975. PMID: 126417 French.
-
Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia.J Clin Pathol. 2009 May;62(5):439-41. doi: 10.1136/jcp.2008.060509. J Clin Pathol. 2009. PMID: 19398595
-
The spectrum of vitamin B12 deficiency.Am Fam Physician. 1990 Jan;41(1):150-62. Am Fam Physician. 1990. PMID: 2278533 Review.
-
Vitamin B12 deficiency.Am Fam Physician. 2003 Mar 1;67(5):979-86. Am Fam Physician. 2003. PMID: 12643357 Review.
Cited by
-
Nutrition and HIV infection in children.Indian J Pediatr. 1996 Sep-Oct;63(5):615-32. doi: 10.1007/BF02730805. Indian J Pediatr. 1996. PMID: 10830030 Review.
-
Changes in parietal cell structure and function in HIV disease.Dig Dis Sci. 1996 Jul;41(7):1398-408. doi: 10.1007/BF02088565. Dig Dis Sci. 1996. PMID: 8689917
-
Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population.PLoS One. 2015 Aug 5;10(8):e0132043. doi: 10.1371/journal.pone.0132043. eCollection 2015. PLoS One. 2015. PMID: 26244370 Free PMC article.
-
The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.Viruses. 2020 Jun 4;12(6):614. doi: 10.3390/v12060614. Viruses. 2020. PMID: 32512929 Free PMC article.
-
Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.Clin Pharmacokinet. 1999 Mar;36(3):233-54. doi: 10.2165/00003088-199936030-00004. Clin Pharmacokinet. 1999. PMID: 10223170 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical